Filing Flows › Nexalin Technology (NXL) › R&D spending
Nexalin Technology (NXL) R&D spending by quarter
Nexalin Technology's R&D spending was $564K in Q2 2026 (second quarter 2026), +63% from Q1 2026. Over the last 7 quarters it ranged from $225K (Q4 2025) to $737K (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $564K | +63% | +150% |
| Q1 2026 | $346K | +54% | -15% |
| Q4 2025 | $225K | -0.7% | -69% |
| Q3 2025 | $227K | +0.3% | — |
| Q2 2025 | $226K | -44% | — |
| Q1 2025 | $406K | -45% | — |
| Q4 2024 | $737K | — | — |
Q2 2026 at a glance
Nexalin Technology, Q2 2026: revenue $12K (-83% year over year), net loss $2.2M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Nexalin Technology's R&D spending?
Nexalin Technology's R&D spending was $564K in Q2 2026 (second quarter 2026), +63% from Q1 2026.
How has Nexalin Technology's R&D spending changed?
Over the last 7 quarters it ranged from $225K (Q4 2025) to $737K (Q4 2024).